• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Clovis Oncology flags possible bankruptcy in 'very near term'

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 09, 2022 at 11:12: AM
via U.S. drugmaker Clovis Oncology CLVS.O said on Wednesday it was likely to file for bankruptcy "in the very near term", as the company struggles to sell its cancer drug Rubraca.

article source
 




Top Bottom
Back
Quote